Cryopreservation of hematopoietic stem (HSC) and progenitor (HPC) cells is crucial for cord blood (CB) banking and transplantation. We evaluated recovery of functional HPC cryopreserved as mononuclear or unseparated cells for up to 23.5 years compared to pre-freeze values of the same CB units. Highly efficient recovery (80-100%) was apparent for granulocytemacrophage and multipotential hematopoietic progenitors, although some collections had reproducible low recovery. Proliferative potential, response to multiple cytokines, and replating of HPC colonies was extensive. CD34 + cells isolated from CB cryopreserved for up to 21 years had long-term (≥ 6 month) engrafting capability in primary and secondary immunodeficient mice reflecting recovery of long-term repopulating, self-renewing HSC. We recovered functionally responsive CD4 + and CD8 + T-lymphocytes, generated induced pluripotent stem (iPS) cells with differentiation representing all 3 germ cell lineages in vitro and in vivo, and detected high proliferative endothelial colony forming cells, results of relevance to CB biology and banking.
Introduction
The first cord blood (CB) transplant saved the life of a young patient with Fanconi anemia using HLA-matched sibling CB cells, 1 a procedure possible by identification and cryopreservation of transplantable hematopoietic progenitor (HPC) and stem (HSC) cells in CB. 2 Over 20,000 CB transplants have treated the same malignant and non-malignant disorders as bone marrow (BM). [3] [4] [5] [6] [7] [8] CB transplantation is possible due to CB banks, and how long CB can be stored in a cryopreserved state with efficient recovery of HSC and HPC is critical for CB banking. We reported highly efficient recovery of CB HPC after 5, 9 10, 10 and 15 11 years, and recovery of HSC after 15 years. 11 We now report efficient recovery of functional HPC up to 21-23.5 years, with more in depth studies on CB HSC engraftment in immune deficient mice, recovery of responsive
T cells, generation of induced pluripotent stem (iPS) cells, 12-14 and detection of endothelial colony forming cells (ECFC). 15
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From Materials and Methods CB cells were scheduled for discard. 2 The study was approved by Institutional Review Board of Indiana University (IU). Cryopreservation, thawing and plating were as reported. 2,9-11 CB was assessed within 36 hrs of collection. Cells were either separated into a mononuclear (MNC) fraction (Ficoll-Hypaque, Pharmacia) and aliquoted into cryotubes (Nalge Nunc) or left unseparated and aliquoted into cryo-freezer bags, 2, 16, 17 in 10% Dimethylsulfoxide and 10%
autologous plasma for eventual analysis of HPC recovery. Percent recovery from MNC or unseparated cryopreserved cells was based on total pre-freeze cells per volume of the exact same CB unit. 2,9-11 After thaw of unseparated cells, CD34 + cells were magnetic bead separated, 11 for HSC engraftment and iPS cell generation studies. CD4 + and CD8 + T-lymphocytes were separated from the CD34 + -depleted cells and stimulated on plates pre-coated with anti-CD3 (OKT3, 0.5µg/ml) and anti-CD28 (clone CD28.2, 1µg/ml) with 10% FBS, 50µM 2ME and 10ng/ml IL-15 as described.
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Immune deficient mouse assay for human CB donor chimerism was as reported, 11 except that recipients were NOD/SCID/IL-2Rg null (NSG).
(Sigma-Aldrich). Medium was replaced at 6 days with above cytokines. At day 7, cells were transferred to mitotically-inactivated MEFs and cultured as for hESCs. 20 iPS cells were also generated at Johns Hopkins using retroviruses expressing Oct4, Sox2, Klf4 and c-Myc.
12
ECFC assay was performed with MNCs isolated from thawed unseparated CB.
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For personal use only. Figure 1A ) compared to the exact same unit's precryopreservation numbers, a recovery similar to 10 and 15 year thaws, that assessed the same plus additional CB units. A range of recoveries was evident, but values were similar whether the same samples were assessed 3 times over 3 years, two times over 1-3 years, or twice on the same day (data not shown). Recovery of CFU-GM and CFU-GEMM from unseparated cryopreserved cells (N=3) was greater than 80% (Data not shown), and consistent with recovery from MNCs. It is not clear why some samples resulted in low efficiency recovery, but assessing the recovery of stored cells by thawing a small sample prior to their possible use in a clinical transplant setting could help identify low recovery CB units, and a decision made as to whether or not to use that unit. Proliferation of HPC was high ( Figure 1B ) and within range for fresh CB.
2, 9-12 Thawed CB is highly responsive to increased colonies from immature HPC when GM-CSF plus SCF and/or FL are used to stimulate them, compared to that of only GM-CSF ( Figure 1C ) demonstrating retention of immature HPC. 9 Thawed CB contain HPC colonies that can be replated ( Figure 1D ), ECFC. High proliferative ECFC have been identified in CB. 15 MNC from thawed unseparated CB stored frozen for up to 21 years formed ECFC colonies, but their size was smaller than colonies from fresh CB ( Figure 2I ). ECFC colony numbers from thawed CB (2-5/10 7 mononuclear cells) was 1/5 to 1/10 numbers from fresh CB, even when colonies from fresh cells vs. those frozen and stored for up to 3-6 months were assayed. Thus, the freezing procedure that works well for efficient recovery of HPC, may not be optimal for storage of ECFCs.
However, ECFCs which can be cryopreserved and recovered may be of value for regenerative medicine, if clinical applicability is proven.
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